Document:

Exhibit 10.1

    Exhibit 10.1

    
 

    TECHNOLOGY
LICENSE

    and

    DISTRIBUTION
AGREEMENT

    AMENDMENT

    

    

    THIS AMENDMENT TO THE TECHNOLOGY
LICENSE and DISTRIBUTION AGREEMENT by and between SMITH YOUNG AND ASSOCIATES,
INC., a Colorado Corporation, its successors, affiliates, and
assigns,  Morton Weisbrot an individual residing in the State of
Arizona, his successors, and assigns (hereinafter all collectively referred to
as the "Licensee") and, FUEL CONCEPTS LLC, an Ohio Limited Liability Company,
its successors, affiliates, and assigns  (hereinafter all collectively
referred to as the “Licensor” or “Owner”)  is made and effective as of
this 18th day of June, 2009  and shall amend certain Sections of the
original THE TECHNOLOGY LICENSE and DISTRIBUTION AGREEMENT made and effective
the 1st day of August, 2008 (hereinafter all collectively referred to as the
Original Agreement).

    

    

    As provided for under Section M of the
Original Agreement, the following text shall amend Section 4
and  Section 5 of the Original Agreement as follows:

    

    

    4.         As
consideration
for this Agreement, Licensee shall pay an initial, one time only payment to
Owner of 1,000,000 shares of Licensee’s $.001 par value common stock. This
payment shall be paid during the initial term of the Agreement and no additional
payments of shares of Licensee’s common or
preferred stock shall be required as consideration for any future option periods
as defined in Section 1 of the Original Agreement. The Shares shall be fully
paid for and non-assessable when issued and shall bear a restrictive
legend  in accordance
with the rules and regulations of the United States Securities and Exchange
Commission.

    

    5.           As additional consideration
for this Agreement, during the first year of the term of the Agreement, Licensee
shall pay to Owner a royalty of Forty ($40.00) US Dollars and Zero
cents from “Net Receipts” on all sales over and above
Six Thousand (6,000) units for the initial calendar year of all products sold
embodying the Technology.  Subsequent to the first year of the
Agreement, and each and every year thereafter including all
option periods, Licensee shall pay to Owner a royalty of Forty ($40.00) US
Dollars and Zero cents from “Net Receipts” on all of products sold
embodying the Technology. This royalty shall be paid out of the net
receipts from the sales of products covered under this
Agreement.  Licensee's "net receipts" are defined as actual revenue
derived and collected from the sale of products sold at Licensee's wholesale
price less hard costs for manufacturing.  No Owner royalty shall be
paid in connection with free or promotional goods. "Hard costs" means all costs
incurred with respect to the manufacture, distribution and sale of products
embodying the Technology including without limitation, graphic design, artwork,
printing, including proofs and color separations, physical manufacturing and
duplication, packaging and shipping of said products. Hard costs do not include
warehousing, accounting, distribution and internet, television, radio and retail
advertising, marketing and promotion.

    

    

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    

    

    IN
WITNESS WHEREOF, the parties hereto have executed this Agreement on the day and
year first above written.

    

    "OWNER"

    FUEL
CONCEPTS, LLC a Ohio Limited Liability Company

    

    EIN#
201849883

    

    ROY
MARITN

    By: Roy
Martin

    Its:
Managing Member

    

    

    "LICENSEE"

    SMITH
YOUNG AND ASSOCIATES, INC.,  a Colorado Corporation

    

    EIN#
__________________________

    

    CARY
PETERSON

    By: Cary
Peterson

    Its:
President

    

    

    "LICENSEE"

    Morton
Weisbrot, an Individual

    

    By:  MORTON
WEISBROT

           Morton
Weisbrotex1033.htm

    THIRD
AMENDMENT TO SECURITIES PURCHASE AGREEMENT

    

    This
Third Amendment to Securities Purchase Agreement (this “Amendment”)
is made as of the 17th day of
June 2009, by and among NewCardio, Inc., a Delaware corporation (the “Company”),
and each purchaser identified on the signature pages to that certain Securities
Purchase Agreement (the “SPA”),
dated as of  December 27, 2007, between Marine Park Holdings, Inc., a
Delaware corporation and the Purchasers identified on the signature pages
thereto (each, including its successors and assigns, a “Purchaser”
and collectively the “Purchasers”).

    

    Capitalized terms defined in the SPA
and not otherwise defined herein shall have the same meanings as ascribed to
them in the SPA.

    

    WHEREAS, by a vote of the Purchasers
holding at least 67% in interest of each class of the Securities that are issued
and outstanding, this Amendment has been approved;

    

    NOW, THEREFORE, in consideration of
the mutual covenants contained in this Agreement, and for other good and
valuable consideration the receipt and adequacy of which are hereby
acknowledged, the undersigned agree as follows:

    

    
      	
              1.  

            	
              The
      SPA is hereby amended by amending the term “Lock-Up
      Period” in its entirety to mean the period commencing on the date
      hereof, and ending on December 31,
2009.

            

    

    

    
      	
              2.  

            	
              Reference
      is made to the letter dated December 31, 2008, between Platinum-Montaur
      Life Sciences, LLC (“Platinum”)
      and the Company (the “Put
      Letter”).  For purposes of the Put Letter, the term “End
      Date” is amended to read July 31,
2009.

            

    

    

    
      	
              3.  

            	
              Except
      as amended hereby, the SPA remains in force and
  effect.

            

    

    

    
      	
              4.  

            	
              This
      Amendment may be executed in counterparts that, together, shall have the
      same effect as if all parties signed this Amendment on the same signature
      page.

            

    

    

    [SIGNATURE PAGES TO THIS THIRD
AMENDMENT TO SECURITIES PURCHASE AGREEMENT FOLLOW]

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    IN
WITNESS WHEREOF, the parties hereto have caused this Third Amendment to
Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

     

    
      
        
          
            	
                    NewCardio,
      Inc.

                     

                  	
                    2350 Mission College Blvd.

                    Suite 1175

                    Santa Clara, CA 95054

                    Facsimile Number: 775-254-5118

                    E-mail:
      rbrounstein@newcardio.com

                     

                     

                  
	
                    By:     
      /s/Richard
      D. Brounstein

                    Name:
      Richard D. Brounstein

                    Title:   Executive
      Vice President, CFO & Secretary

                     

                  	 
      

          

        

      

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    

    [PURCHASER
SIGNATURE PAGE TO THIRD AMENDMENT TO SECURITIES PURCHASE AGREEMENT]

    

     

    IN
WITNESS WHEREOF, the undersigned has caused this Third Amendment to Securities
Purchase Agreement to be duly executed by its authorized signatories as of the
date first indicated above.

     

    Name of
Purchaser: Vision Opportunity Master Fund, Ltd.

     

    Signature of Authorized Signatory of
Purchaser: /s/Carl
Kleidman

     

    Name of
Authorized Signatory: Carl Kleidman

     

    Title of
Authorized Signatory: Managing Director

     

    Email
Address of Authorized Signatory:
_______________________________________

     

    Fax
Number of Authorized Signatory:
_________________________________________

     

    Address
for Notice of Purchaser: c/o Vision Capital Advisors

    20 W 55th Street,
5th
Fl.

    New York, NY 10019

    Attn.:  Jess Jones or Kim
Gabriel

    

    

    

    [SIGNATURE
PAGES CONTINUE]

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    

    [PURCHASER
SIGNATURE PAGE TO THIRD AMENDMENT TO SECURITIES PURCHASE AGREEMENT]

    

     

    IN
WITNESS WHEREOF, the undersigned has caused this Third Amendment to Securities
Purchase Agreement to be duly executed by its authorized signatories as of the
date first indicated above.

     

    Name of
Purchaser: Vision Capital Advantage Fund, L.P.

     

    Signature of Authorized Signatory of
Purchaser: /s/Carl
Kleidman

     

    Name of
Authorized Signatory: Carl Kleidman

     

    Title of
Authorized Signatory: Managing Director

     

    Email
Address of Authorized Signatory:
_______________________________________

     

    Fax
Number of Authorized Signatory:
_________________________________________

     

    Address
for Notice of Purchaser:  c/o Vision Capital Advisors

    20 W 55th Street,
5th
Fl.

    New York, NY 10019

    Attn.:  Jess Jones or Kim
Gabriel

    

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

    

    [PURCHASER
SIGNATURE PAGE TO THIRD AMENDMENT TO SECURITIES PURCHASE AGREEMENT]

    

     

    IN
WITNESS WHEREOF, the undersigned has caused this Third Amendment to Securities
Purchase Agreement to be duly executed by its authorized signatories as of the
date first indicated above.

     

    

    

    Name of
Purchaser: Platinum-Montaur Life Sciences, LLC

     

    Signature of Authorized Signatory of
Purchaser: /s/ Michael
M. Goldberg

     

    Name of
Authorized Signatory: Michael Goldberg

     

    Title of
Authorized Signatory: Portfolio Manager

     

    Email
Address of Authorized Signatory: mgoldberg@montaurcap.com

     

    Fax
Number of Authorized Signatory: 212-271-7855

     

    Address
for Notice of Purchaser:  c/o Michael Goldberg

                                                          
 152 S.
57th
Street, 4th
Floor

                                                           
New
York, NY 10019

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]